GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's other long-term assets for the quarter that ended in Dec. 2013 was $1.99 Mil.
Synageva BioPharma Corp's quarterly other long-term assets increased from Jun. 2013 ($0.71 Mil) to Sep. 2013 ($0.73 Mil) and increased from Sep. 2013 ($0.73 Mil) to Dec. 2013 ($1.99 Mil).
Synageva BioPharma Corp's annual other long-term assets declined from Dec. 2011 ($0.06 Mil) to Dec. 2012 ($0.04 Mil) but then increased from Dec. 2012 ($0.04 Mil) to Dec. 2013 ($1.99 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Synageva BioPharma Corp Annual Data
|Other Long-Term Assets||4.53||6.27||7.68||8.95||10.38||6.92||0.06||0.06||0.04||1.99|
Synageva BioPharma Corp Quarterly Data
|Other Long-Term Assets||0.47||0.06||0.06||0.04||0.07||0.04||0.71||0.71||0.73||1.99|